Supplement: CRISPR screens of population relevant genes governing toxicant resilience
补充:CRISPR 筛选控制毒物抵抗力的群体相关基因
基本信息
- 批准号:10720972
- 负责人:
- 金额:$ 36.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-14 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Summary
The goal of this supplement is to enhance diversity in the research workforce through support of a disabled
graduate student in response to PA-21-071(Research Supplement to Promote Diversity in Health-Related
Research). This supplement will enable the disabled student to work in the laboratory of the PI of parent grant
by providing support for his stipend and tuition, as well as allowing the hiring of a dedicated technical research
assistant for the components of the proposed work requiring fine motor capabilities. In addition, mentorship,
career development support, targeted training efforts, and reasonable accommodations will enable the student to
continue to pursue a scientific career while navigating the challenges presented by his disability. The parent
grant focuses on GXE interactions with exogenous stressors but posited application to GXE interactions with
endogenous stressors, such as a pre-existing monogenic genetic disorder, which is the focus of the supplement.
We selected the monogenic disorder, Friedrich’s ataxia (FRDA), a progressive neurodegenerative disorder most
commonly due to triplet repeat mutations in the frataxin gene. While triplet repeat length plays a role in the
disease presentation, other unknown genetic and environmental factors clearly contribute. We will assess the
capability of our novel targeted functional screening approach to identify genes which when disrupted could
modulate the cellular phenotype of FRDA. As with the parent grant, the work will focus on the set of ~1490
genes with common LOF mutations in the population and will assess functional effect by assessing changes in
the transcriptional phenotype of relevant cells. This work if successful could provide important insight into
common LOF variants that impact the presentation and progression of Friedrich’s ataxia. This functional
screening approach using transcriptional phenotypic endpoints could have general applicability to any genetic
disease and enable identification of potentially functionally significant and population relevant genetic variants
impacting the phenotypic manifestations of the disease.
概括
这种补充的目的是通过支持残疾人来增强研究劳动力的多样性
研究生响应PA-21-071(促进与健康相关的多样性的研究补充
研究)。这种补充剂将使残疾学生能够在父母赠款的PI实验室工作
通过为他的压力和学费提供支持,并允许雇用专门的技术研究
需要精细运动能力的拟议工作组成部分的助手。此外,Mentalship,
职业发展支持,有针对性的培训工作以及合理的住宿将使学生能够
继续从事科学职业,同时导致其残疾带来的挑战。父母
格兰特专注于与外源压力源的GXE相互作用,但已发布到与GXE相互作用的应用
内源性应激源,例如先前存在的单基因遗传疾病,这是补充剂的重点。
我们选择了单基因疾病,弗里德里希共济失调(FRDA),这是一种进行性神经退行性障碍
通常是由于Frataxin基因中的三胞胎重复突变引起的。而三胞胎重复长度在
疾病表现,其他未知的遗传和环境因素显然促成。我们将评估
我们新颖的靶向功能筛选方法的能力鉴定基因,当受到干扰时
调节FRDA的细胞表型。与父母赠款一样,工作将重点放在〜1490的集合上
人群中具有常见LOF突变的基因,将通过评估变化来评估功能效应
相关细胞的转录表型。这项工作如果成功可以提供重要的见解
影响弗里德里希共济失调的表现和发展的常见LOF变体。这个功能
使用转录表型端点的筛选方法可能对任何通用的一般适用性
疾病并能够鉴定潜在的功能意义和种群相关的遗传变异
影响疾病的表型表现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
CHRISTOPHER D VULP...的其他基金
CRISPR screens of population relevant genes governing toxicant resilience
CRISPR 筛选控制毒物抵抗力的群体相关基因
- 批准号:1033772610337726
- 财政年份:2022
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
CRISPR screens of population relevant genes governing toxicant resilience
CRISPR 筛选控制毒物抵抗力的群体相关基因
- 批准号:1057319310573193
- 财政年份:2022
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
Functional Profiling to Identify Mitochondria-cell Signaling Networks
识别线粒体细胞信号网络的功能分析
- 批准号:90689239068923
- 财政年份:2015
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
An integrated molecular approach to understand variation in iron metabolism
了解铁代谢变化的综合分子方法
- 批准号:86690028669002
- 财政年份:2012
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
An integrated molecular approach to understand variation in iron metabolism
了解铁代谢变化的综合分子方法
- 批准号:88858448885844
- 财政年份:2012
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
An integrated molecular approach to understand variation in iron metabolism
了解铁代谢变化的综合分子方法
- 批准号:82382728238272
- 财政年份:2012
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
An integrated molecular approach to understand variation in iron metabolism
了解铁代谢变化的综合分子方法
- 批准号:85015368501536
- 财政年份:2012
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
Project 2: Functional Profiling of Susceptibility Genes
项目2:易感基因的功能分析
- 批准号:80631328063132
- 财政年份:2010
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
Integrated nanoparticle characterizaton and toxicity assessment
综合纳米颗粒表征和毒性评估
- 批准号:79397947939794
- 财政年份:2009
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
Integrated nanoparticle characterizaton and toxicity assessment
综合纳米颗粒表征和毒性评估
- 批准号:78549857854985
- 财政年份:2009
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
- 批准号:32371910
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of POU4F1 in a Novel Form of Ataxia
POU4F1 在新型共济失调中的作用
- 批准号:1074138210741382
- 财政年份:2023
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
New approaches to understanding BK channelopathies at the molecular level of single channels
在单通道分子水平上了解 BK 通道病的新方法
- 批准号:1063969010639690
- 财政年份:2023
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
RLIP, Mitochondrial Dysfunction in Alzheimer’s Disease
RLIP,阿尔茨海默病中的线粒体功能障碍
- 批准号:1090102510901025
- 财政年份:2023
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia
项目 2:弗里德赖希共济失调的治疗性基因编辑
- 批准号:1066876810668768
- 财政年份:2023
- 资助金额:$ 36.64万$ 36.64万
- 项目类别:
Molecular Pathogenesis of spinocerebellar ataxia type 12
12 型脊髓小脑共济失调的分子发病机制
- 批准号:1057973610579736
- 财政年份:2023
- 资助金额:$ 36.64万$ 36.64万
- 项目类别: